Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a phone app help pregnant women stick with addiction treatment?

NCT ID NCT06999811

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 36 times

Summary

This study tests whether a special therapy program with a mobile app helps pregnant people stay on their buprenorphine medication for opioid use disorder, compared to just logging their doses. About 37 pregnant women will be randomly assigned to either the app-based therapy or daily medication tracking. The goal is to see if the extra support improves treatment retention and engagement.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29403, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

behavioral intervention (EMPWR) with mobile app

What this could lead to

If successful, this could show that a therapy app plus counseling helps pregnant people stick with their opioid treatment, improving health for mother and baby.

What could go wrong

This is a very small early feasibility study (37 people), so results may not apply widely. The therapy is extra work and may not improve retention over simple monitoring.

Conditions

The condition(s) this trial relates to.

anxiety disorder opiate dependence Psychological Well-Being sleep-wake disorder substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.